8:29 AM
Leo Group India
| ||
| National Pharmaceutical Pricing Policy, 2012 to replace DPCO domain-B The National Pharmaceuticals Pricing Policy, 2012 seeks to regulate drug prices on the basis of essentiality of the drug through market-based pricing (MBP) of formulations as opposed to regulating bulk drug prices through cost-based pricing (CBP) of ... See all stories on this topic » | ||
| Man arrested for illegal Internet sale of unregistered pharmaceutical products ... 7thSpace Interactive (press release) Hong Kong (HKSAR) - A 30-year-old man was arrested today (December 12) in a joint operation by the Department of Health (DH) and the Police in Sheung Shui for illegal sale of "Geftinat 250mg tablets", an unregistered pharmaceutical product containing a ... See all stories on this topic » | ||
| TESSENDERLO : Group completes sale of pharmaceutical ingredients activities 4-traders Tessenderlo Group (NYSE Euronext: TESB) announced today that it has completed the sale of its pharmaceutical ingredients activities in Calaire (France) and Farchemia (Italy) to International Chemical Investors Group (ICIG), a private industrial holding ... See all stories on this topic » | ||
| Bosch intends to purchase minority share of Industrial Pharmaceutical ... Packaging Europe Bosch Packaging Services, Inc., has announced that it intends to purchase a minority share of Industrial Pharmaceutical Resources, Inc., (IPR, Inc.) of Bartlett, Ill., which refurbishes, upgrades and manufactures control and automation products and ... See all stories on this topic » | ||
| Teva Pharmaceutical Industries Limited - Shareholder/Analyst Call Seeking Alpha Good afternoon, everyone. On behalf of Teva's Board of Directors and executive officers, I'd like to welcome all of you to the Sentry Center here in New York to Teva's Investor Day 2012. For those of you joining on the webcast, I'd like to welcome you ... See all stories on this topic » | ||
| Pernix Thera rescues struggling Somaxon with stock deal worth $25 million The Pharma Letter Troubled US drugmaker Somaxon Pharmaceuticals (Nasdaq: SOMX) saw its shares leap around 85% to $2.74 yesterday morning, when it was revealed that fellow USA-based Pernix Therapeutics (NYSE: PTX) had agreed a merger accord in a stock-for-stock ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment